USR Tarragona-Reus

RESPONSABLE
avatar_investigadors.jpg
Enric Aragonès Benaiges
earagones.tgn.ics@gencat.cat
Reus-Tgn - USR equip

Publicaciones

Interim Results from the VAC4EU Post-Authorization Safety Study (PASS) Among Recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) Vaccine in Europe

D. WEIBEL, C. DE LUISE, A. ROYO, O. RYAN, T. VAZ, J. AGUADO, J. MARSAL, X. MARTINEZ, R. WEINRIB, N. YEFIMENKO, E. PALÀ, B. POBLADOR-PLOU, A. GIMENO-MIGUEL, A. SANTOS-MEJÍAS, E. MARCONI, E. BARBIERI, L. STONA, T. LYSEN, D. ROY, G. HYERACI, A. GIRARDI, A. LUPATTELLI, A. DESALEGN, F. VILLALOBOS, C. BISSACCO, K. KENDRICK, R. GARG, H. RUBINO, M. STURKENBOOM and A. ARANA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

Cohort Event Monitoring of COVID-19 Vaccine Safety Using Patient-Reported Outcomes in Pregnant Women

E. MAISONNEUVE, F. CICCIMARRA, N. LUXI, C. BELLITTO, M. RAETHKE, F. VAN HUNSEL, T. LIEBER, E. MULDER, F. RIEFOLO, F. VILLALOBOS, N. THURIN, F. MARQUES, K. MORTON, F. O'SHAUGHNESSY, S. SONDERLICHOVÁ, A. FARCAS, S. SIISKONEN, D. BAUD, J. GIELE-ESHUIS, M. STURKENBOOM, G. TRIFIRÒ and A. PANCHAUD
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

Impact of Data Source Diversity on the Distribution of Key Variables in Pregnancy Cohorts Based on the ConcePTION Pregnancy Algorithm Leveraging a Random Forest Imputation Model

A. GIRARDI, G. LIMONCELLA, G. HYERACI, G. ROBERTO, C. BARTOLINI, O. PAOLETTI, D. MESSINA, F. VILLALOBOS, C. BISSACCO, J. VAN DEN BERG, E. HOUBEN, K. SANTACÀ, V. IENTILE, Y. INGRASCIOTTA, G. TRIFIRÒ, V. HOXHAJ, C. DURÁN, J. RIERA-ARNAU, P. GARCIA, M. MARTÍN-PÉREZ, C. HUERTA-ALVAREZ, A. LLORENTE-GARCIA, F. SÁNCHEZ-SÁEZ, G. SANFÉLIX-GIMENO, C. RODRÍGUEZ-BERNAL, R. LASSALLE, J. JOVÉ, M. BERNARD, N. THURIN, S. JORDAN, D. THAYER, H. EVANS, A. COLDEA, M. MANFRINI, M. VAN GELDER, S. HAYATI, T. SCHINK, M. TARI, R. PAJOUHESHNIA, A. AFONSO, M. LE NOAN-LAINÉ, D. MOLGAARD-NIELSEN, M. CUNNINGTON, C. DODD, M. STURKENBOOM, H. NORDENG and R. GINI
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2024 Nov 1;

What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European «Covid Vaccine Monitor» Active Surveillance Study.

Bellitto C, Luxi N, Ciccimarra F, L'Abbate L, Raethke M, van Hunsel F, Lieber T, Mulder E, Riefolo F, Villalobos F, Thurin NH, Marques FB, Morton K, O'Shaughnessy F, Sonderlichová S, Farcas A, Janneke GE, Sturkenboom MC and Trifirò G
DRUG SAFETY. 2024 Oct 1; . doi:10.1007/s40264-024-01449-x; PMID:38907947

Safety of COVID-19 Vaccines among People with History of Allergy: A European Active Surveillance Study.

Luxi N, Ciccimarra F, Bellitto C, Raethke M, van Hunsel F, Lieber T, Mulder E, L'Abbate L, Marques FB, Furci F, Farcas A, Giele-Eshuis J, Morton K, Sonderlichová S, Thurin NH, Villalobos F, Riefolo F, Sturkenboom MC and Trifirò G
Vaccines. 2024 Sep 17; . doi:10.3390/vaccines12091059; PMID:39340089

Patronat

Col·laboradors

Acreditacions